 |
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither Road
Rockville, Maryland 20850
Prepared by:
Ann G. Zauber, PhD (1)
Iris Lansdorp-Vogelaar, MS (2)
Amy B. Knudsen, PhD (3)
Janneke Wilschut, MS (2)
Marjolein van Ballegooijen, MD, PhD (2)
Karen M. Kuntz, ScD (4)
Department of Epidemiology and Biostatistics, memorial Sloan-Kettering Cancer Center, New York, NY
Department of Public Health, Erasmus MC, Rotterdam, the Netherlands
Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA
4Division of Health Policy and Management, University of Minnesota, Minneapolis, MN
AHRQ Publication No. 08-05124-EF-2.
March 2009
This report was funded by the National Cancer Institute (U01-CA-088204, U01-CA-097426, and U01-CA-115953) and the Agency for Healthcare Research and Quality (HHSP233200700350P, HHSP233200700210P, and HHSP233200700196P).
The findings and conclusions in this document are those of the authors who are responsible for its contents; the finding s and conclusions do not necessarily represent the views of AHRQ. No statement in this article should be construed as an official position of the Agency for Healthcare Research and Quality or of the U.S. Department of Health and Human Services.
This report may be used, in whole or in part, as the basis for the development of clinical practice guidelines and other quality enhancement tools, or as a basis for reimbursement and coverage policies. AHRQ or U.S. Department of Health and Human Services endorsement of such derivative products may not be stated or implied.
Corresponding Author:
Ann G. Zauber, PhD
Department of Epidemiology and Biostatistics
Memorial Sloan-Kettering Cancer Center
307 East 63rd Street, New York, NY 10065
646-735-8160 (office)
646-735-0012 (fax)
Suggested citation: Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM. Evaluating Test Strategies for Colorectal Cancer Screening—Age to Begin, Age to Stop, and Timing of Screening Intervals: A Decision Analysis of Colorectal Cancer Screening for the U.S. Preventive Services Task Force from the Cancer Intervention and Surveillance Modeling Network (CISNET). Evidence Synthesis No. 65, Part 2. AHRQ Publication No. 08-05124-EF-2. Rockville, Maryland, Agency for Healthcare Research and Quality, March 2009.
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither Road
Rockville, Maryland 20850
Prepared by:
Ann G. Zauber, PhD (1)
Iris Lansdorp-Vogelaar, MS (2)
Amy B. Knudsen, PhD (3)
Janneke Wilschut, MS (2)
Marjolein van Ballegooijen, MD, PhD (2)
Karen M. Kuntz, ScD (4)
Department of Epidemiology and Biostatistics, memorial Sloan-Kettering Cancer Center, New York, NY
Department of Public Health, Erasmus MC, Rotterdam, the Netherlands
Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA
4Division of Health Policy and Management, University of Minnesota, Minneapolis, MN
AHRQ Publication No. 08-05124-EF-2.
March 2009
This report was funded by the National Cancer Institute (U01-CA-088204, U01-CA-097426, and U01-CA-115953) and the Agency for Healthcare Research and Quality (HHSP233200700350P, HHSP233200700210P, and HHSP233200700196P).
The findings and conclusions in this document are those of the authors who are responsible for its contents; the finding s and conclusions do not necessarily represent the views of AHRQ. No statement in this article should be construed as an official position of the Agency for Healthcare Research and Quality or of the U.S. Department of Health and Human Services.
This report may be used, in whole or in part, as the basis for the development of clinical practice guidelines and other quality enhancement tools, or as a basis for reimbursement and coverage policies. AHRQ or U.S. Department of Health and Human Services endorsement of such derivative products may not be stated or implied.
Corresponding Author:
Ann G. Zauber, PhD
Department of Epidemiology and Biostatistics
Memorial Sloan-Kettering Cancer Center
307 East 63rd Street, New York, NY 10065
646-735-8160 (office)
646-735-0012 (fax)
Suggested citation: Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM. Evaluating Test Strategies for Colorectal Cancer Screening—Age to Begin, Age to Stop, and Timing of Screening Intervals: A Decision Analysis of Colorectal Cancer Screening for the U.S. Preventive Services Task Force from the Cancer Intervention and Surveillance Modeling Network (CISNET). Evidence Synthesis No. 65, Part 2. AHRQ Publication No. 08-05124-EF-2. Rockville, Maryland, Agency for Healthcare Research and Quality, March 2009.
Appendix 1: Model descriptions
Appendix 2. Summary results per 1000 40-year old individuals for all strategies and both models
Appendix 3: Results including starting at age 40 in efficient and near-efficient frontiers
